168 related articles for article (PubMed ID: 35733030)
1. Amphicrine Medullary Thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.
Khandakar H; Agarwal S; Sharma MC; Kandasamy D; Bal C; Rathode Y; Aphale R
Endocr Pathol; 2022 Sep; 33(3):378-387. PubMed ID: 35733030
[TBL] [Abstract][Full Text] [Related]
2. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
3. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
[TBL] [Abstract][Full Text] [Related]
4. Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series.
van den Broek MFM; Rijks EBG; Nikkels PGJ; Wolters VM; van Es RJJ; van Santen HM; van Nesselrooij BPM; Vriens MR; van Leeuwaarde RS; Valk GD; Verrijn Stuart AA
Endocrine; 2021 Jun; 72(3):905-914. PubMed ID: 33474713
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
Acton DS; Velthuyzen D; Lips CJ; Höppener JW
Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on MEN2B.
Castinetti F; Moley J; Mulligan L; Waguespack SG
Endocr Relat Cancer; 2018 Feb; 25(2):T29-T39. PubMed ID: 28698189
[TBL] [Abstract][Full Text] [Related]
8. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the genotype-phenotype correlation in children with medullary thyroid carcinoma: A report from the GPOH-MET registry.
Kuhlen M; Frühwald MC; Dunstheimer DPA; Vorwerk P; Redlich A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28171. PubMed ID: 31925938
[TBL] [Abstract][Full Text] [Related]
10. A Novel Double
Mathew A; Latteyer S; Frank-Raue K; Moeller LC; Zwanziger D; Mengel M; Führer D; Tiedje V
Thyroid; 2021 Feb; 31(2):327-329. PubMed ID: 32546069
[No Abstract] [Full Text] [Related]
11. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
[TBL] [Abstract][Full Text] [Related]
12. MEN2B syndrome - paediatric case report.
Zendran I; Szlasa W; Bis G; Sondaj K; Barg E
Pediatr Endocrinol Diabetes Metab; 2020; 26(4):211-215. PubMed ID: 33191720
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
14. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
Wray CJ; Rich TA; Waguespack SG; Lee JE; Perrier ND; Evans DB
Ann Surg Oncol; 2008 Jan; 15(1):293-301. PubMed ID: 17963006
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
[TBL] [Abstract][Full Text] [Related]
17. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA; Nosé V; Sadow PM
Endocr Pathol; 2021 Mar; 32(1):35-43. PubMed ID: 33492588
[TBL] [Abstract][Full Text] [Related]
18. The pathology of preclinical medullary thyroid carcinoma.
Ashworth M
Endocr Pathol; 2004; 15(3):227-31. PubMed ID: 15640548
[TBL] [Abstract][Full Text] [Related]
19. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Fox E; Widemann BC; Chuk MK; Marcus L; Aikin A; Whitcomb PO; Merino MJ; Lodish M; Dombi E; Steinberg SM; Wells SA; Balis FM
Clin Cancer Res; 2013 Aug; 19(15):4239-48. PubMed ID: 23766359
[TBL] [Abstract][Full Text] [Related]
20. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]